HomeClinical TopicsOzone-depleting inhalers to be phased out

Ozone-depleting inhalers to be phased out

On April 13, the U.S. Food and Drug Administration announced that seven metered-dose inhalers used for asthma and chronic obstructive pulmonary disease will gradually be removed from the market because they contain ozone-depleting cholorofluorocarbons (CFCs). Find more details and the schedule for removal at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm.


Please enter your comment!
Please enter your name here

Most Recent Content